China SXT Pharmaceuticals Secures $760K in Highly Dilutive Offering at Deep Discount

summarizeSummary

China SXT Pharmaceuticals completed a direct offering of 2 million shares at $0.38 per share, raising $760,000, which is highly dilutive and priced at a deep discount to recent market prices.

check_boxKey Events

• Direct Offering Completed

  The company sold 2,000,000 Class A Ordinary Shares directly to investors through a securities purchase agreement dated April 7, 2026.

• Significant Capital Raised

  The offering generated aggregate gross proceeds of $760,000 for the company.

• Deep Discount Pricing

  Shares were sold at $0.38 per share, an approximate 81% discount compared to the last reported sale price of $2.07 on April 7, 2026.

• Substantial Share Dilution

  The 2,000,000 new shares represent over 200% of the 958,077 Class A Ordinary Shares outstanding immediately before the offering, significantly diluting existing shareholders.

auto_awesomeAnalysis

China SXT Pharmaceuticals has completed a direct offering of 2,000,000 Class A Ordinary Shares, generating gross proceeds of $760,000. This offering is highly dilutive, representing over 200% of the shares outstanding immediately prior to the transaction. The shares were sold at $0.38 each, an approximate 81% discount to the last reported sale price of $2.07 on April 7, 2026. The substantial discount and significant dilution indicate a pressing need for capital, which could negatively impact existing shareholders. Proceeds are earmarked for general corporate purposes and working capital.